NACE 46851 in Harelbeke · BE. Official registry identity, filed financial evidence and a rounded indicative valuation range on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2023. This is not a current market value or asking price.
Based on filed company accountsCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
You have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for VERNOPHARMA uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
VERNOPHARMA, a business in NACE sector 46851, is registered at an address in Harelbeke, Belgium. The company was founded in 1990, incorporated as a Besloten vennootschap met beperkte aansprakelijkhe.
VERNOPHARMA is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0441952982 and VAT number BE0441952982. This profile consolidates KBO registry, NBB/CBSO annual accounts into one indexable company dossier.
Companies in this NACE 46851 band file annual accounts with NBB/CBSO.
Across the 2022-2023 window the gross-margin line has grown, moving from €52,690 to €64,011. EBITDA for 2023 comes in at €26,589. Because this line is gross margin from an abbreviated filing, not reported turnover, it is treated as public context rather than an automatic valuation base.
The most recent annual filing covers 2023.
The historical indicative range for VERNOPHARMA is a point-in-time research aid, not a current market value or asking price; current owner or advisor data is required for a full valuation.
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 2023 | €64,011 | €26,589 | €212,583 | €115,479 | - |
| 2022 | €52,690 | €16,613 | €195,938 | €97,156 | - |
VERNOPHARMA was founded in 1990 and is registered with Belgian Crossroads Bank for Enterprises (KBO), incorporated as a Besloten vennootschap met beperkte aansprakelijkhe.
VERNOPHARMA is registered under NACE 46851: NACE 46851. That places the business within the Belgian cluster for this activity.
According to the company registry, VERNOPHARMA is based in Harelbeke, BE.
The most recently filed annual accounts cover fiscal year 2023, publicly available via Belgian Crossroads Bank for Enterprises (KBO).
This page shows a rounded historical indicative range for VERNOPHARMA, based on the latest available public filing for fiscal year 2023. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Public profiles for peers in the same industry and country. Click through to compare filings and indicative valuations.
